"We are a member site of ENCORE Research Group, a premier clinical research organization that has conducted more than 2,500 clinical trials over 20 years and has worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you."

During the past decade, Fleming Island Center for Clinical Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fleming Island Center for Clinical Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Angion Biomedica Corp" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fleming Island Center for Clinical Research" #1 collaborator was "Biogen" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator, "Clinical Accelerator" with 1 trials as a collaborator and "Everest Clinical Research" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Fleming Island Center for Clinical Research" are "Hot Flashes" (2 trials), "Influenza, Human" (2 trials), "Insomnia Disorder" (2 trials), "Osteoarthritis" (2 trials) and "Acute Kidney Injury" (1 trials). Many other conditions were trialed in "Fleming Island Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Fleming Island Center for Clinical Research" are "Drug" (14 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "fezolinetant" (2 trials), "placebo" (2 trials), "ANG-3777" (1 trials) and "APT-1011" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fleming Island Center for Clinical Research" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Fleming Island Center for Clinical Research". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Fleming Island Center for Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fleming Island Center for Clinical Research, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".